http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0212209-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1d7bda35f62bf8e59c55e856b3113f74 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S128-08 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L33-0023 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L33-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L33-10 |
| filingDate | 1986-07-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cd89a66684604aeb6d1366591c69a017 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_049e9e034f25e623ae9b0d46f363b8cb http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0c850164194bbefeb3cef70b0136986c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ff710a7db312acbc733c380a41382ed7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cefd68b558bf8e4aadd9d5b65728617d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2e9724ab40ca268a7ff680c9c14db366 |
| publicationDate | 1987-03-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | EP-0212209-A1 |
| titleOfInvention | A production process of an antithrombogenic and antiadhesive material for medical use |
| abstract | This invention concerns a production process of an antithrombogenic and antiadhesive material which can favorably be used as artificial blood vessels, artificial valves, grafting patches for cardiovascular organs, artificial heart catheters and so on. The gist of this invention is constructed substantially of subjecting glycidyltrialkylammonium halide such as glycidyltrimethylammonium chloride to the reaction with a material comprising pure collagen or collagen and other components like mucopolysaccharide in order to introduce a cationic quaternary functional group in collagen molecules of the material and then subjecting heparin to the ionic combination with the cationic functional group introduced. Meanwhile, in advance of the above chemical treatment, the material is prepared from dog's blood vessel by removing proteins except collagen, from cow's Achilles tendon by crushing into powder, from human amnion by rinsing in distilled water or from polyester knit tube by coating its inside with powdered collagen, for example. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-2877669-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-03066957-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006037770-A1 |
| priorityDate | 1985-07-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 63.